Data / Form D filings / Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc.: Form D filing
Sensei Biotherapeutics, Inc., a biotechnology company in Rockville, MD, filed a Form D with the SEC in 2026. The latest, on March 4, 2026, reports $348.9 million sold of a $348.9 million offering to 104 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1405 RESEARCH BLVD, SUITE 125, Rockville, MD, 20850
- Phone
- (240) 243-8000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1829802
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | New notice | $348,906,500 | $348,906,500 | 104 | Feb 17, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Gerry | Executive Officer, Director | |
| Josiah Craver | Executive Officer | |
| Tom Ricks | Director | |
| Anand Kiran Parikh | Executive Officer, Director | |
| Phillip B. Donenberg | Director | |
| Bob Holmen | Director | |
| Kristian Humer | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Mar 2, 2026 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Sensei Biotherapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.